CELLECTAR BIOSCIENCES INC (CLRB) Stock Analyst Earnings Estimates
NASDAQ:CLRB - Nasdaq - US15117F8077 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 208.14% | N/A 545.83% | N/A -67.27% | N/A 79.95% | N/A 31.00% | N/A 27.66% | N/A 87.06% | |||||||||||
| EBITDA YoY % growth | -9.3M | -8.2M 11.83% | -9.09M -10.85% | -12.05M -32.56% | -11.57M 3.98% | -14.05M -21.43% | -15.16M -7.90% | -23.98M -58.18% | -28.66M -19.52% | -38.768M -35.27% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.67M | -8.56M 11.48% | -9.45M -10.40% | -13.6M -43.92% | -11.65M 14.34% | -14.18M -21.72% | -15.3M -7.90% | -24.13M -57.71% | -28.81M -19.39% | -38.961M -35.23% | N/A -40.34% | N/A 39.16% | N/A -62.33% | N/A 156.93% | N/A -192.67% | N/A 67.95% | N/A 158.07% | N/A 282.38% | N/A 206.54% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -107.00 -94.26% | -60.60 43.36% | -19.70 67.49% | -9.00 54.31% | -4.30 52.22% | -4.05 5.81% | -2.93 27.65% | N/A 44.47% | N/A 55.17% | N/A -23.43% | N/A 136.26% | N/A -274.22% | N/A 61.43% | N/A 60.47% | N/A 100.00% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 41.06% | -0.33 55.89% | -0.30 -886.00% | -0.29 28.60% | -0.23 34.75% | -0.20 37.50% | -0.10 65.52% | -0.06 78.57% | 0.03 113.04% |
| Revenue Q2Q % growth | 6.12M | 8.16M | 12.24M | 18.36M | 21.42M 250.00% | 28.56M 250.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.66M -16.83% | -14.636M -21.96% | -15.142M -10.49% | -14.499M -8.79% | -5.923M 59.60% | -14.688M -0.35% | -11.22M 25.90% | -7.956M 45.13% | -1.122M 81.06% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.40 51.81% | -0.38 | -0.02 | -5.28% |
| Q2 2024 Q2Q % growth | -0.03 95.89% | -0.35 | 0.32 | 91.47% |
| Q1 2024 Q2Q % growth | -0.74 2.63% | -0.57 | -0.17 | -28.79% |
| Q4 2023 Q2Q % growth | -0.61 -10.91% | -0.58 | -0.03 | -4.92% |
| Q3 2023 Q2Q % growth | -0.83 35.16% | -0.54 | -0.29 | -55.00% |
| Q2 2023 Q2Q % growth | -0.73 40.16% | -0.65 | -0.08 | -12.41% |
| Q1 2023 Q2Q % growth | -0.76 24.00% | -0.88 | 0.12 | 14.11% |
| Q4 2022 Q2Q % growth | -0.55 38.89% | -1.10 | 0.55 | 49.84% |
| Q3 2022 Q2Q % growth | -1.28 -28.00% | -1.24 | -0.04 | -3.43% |
| Q2 2022 Q2Q % growth | -1.22 -10.91% | -1.06 | -0.16 | -15.56% |
| Q1 2022 Q2Q % growth | -1.00 23.08% | -1.02 | 0.02 | 1.96% |
| Q4 2021 Q2Q % growth | -0.90 -28.57% | -1.05 | 0.15 | 13.92% |
| Q3 2021 Q2Q % growth | -1.00 33.33% | -1.12 | 0.12 | 10.87% |
| Q2 2021 Q2Q % growth | -1.10 57.69% | -1.17 | 0.07 | 5.95% |
| Q1 2021 Q2Q % growth | -1.30 69.05% | -1.04 | -0.26 | -24.46% |
| Q4 2020 Q2Q % growth | -0.70 78.79% | -1.49 | 0.79 | 52.99% |
| Q3 2020 Q2Q % growth | -1.50 64.29% | -2.04 | 0.54 | 26.47% |
| Q2 2020 Q2Q % growth | -2.60 43.48% | -3.02 | 0.42 | 13.88% |
| Q1 2020 Q2Q % growth | -4.20 44.74% | -3.54 | -0.66 | -18.78% |
| Q4 2019 Q2Q % growth | -3.30 | -3.77 | 0.47 | 12.56% |
| Q3 2019 Q2Q % growth | -4.20 | -3.88 | -0.32 | -8.36% |
| Q2 2019 Q2Q % growth | -4.60 | -7.09 | 2.49 | 35.11% |
| Q1 2019 Q2Q % growth | -7.60 | -7.55 | -0.05 | -0.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.7% | 0% | 9.89% |
| Revenue | N/A | N/A | N/A | N/A |